Wang et al. have shown that the level of CD82 antigen (CD82) in exosomes is negatively correlated with that in tissue for breast cancer patients, and the content of serum exosomal CD82 is higher in cancer group than that in the benign group and healthy control group. Here, CD82 is linked to cancer.